Xing Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Xing Chen has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Chongjian Wang
Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, PR China
1 shared publication - Chuman Lin
Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China
1 shared publication - Fei Tian
Department of Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou 510080, China
1 shared publication - Hualiang Lin
Department of Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, China
1 shared publication - Jin Feng
Department of Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou 510080, China
1 shared publication - Juan Zhu
Departments of Neurology (J.Z., K.L., Q.C., Z.L., Y.H., Y.C., C.L., M.Y., K.H., S.P.), Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
1 shared publication
Latest Publications
- Open Access
- 31 March 2026
- Published by Scilight Press Pty Ltd in Environmental Change and Disease Dynamics
- Vol. 1 (1) , 1
Sunshine Duration and Dementia: Mediating Role of Vitamin D, Calcium, and Accelerated Brain Aging
The current evidence regarding the relationship between sunlight exposure and dementia is limited and inconclusive, with potential modifiers and underlying mechanisms remaining largely unexplored. A total of 499,627 participants from the UK Biobank were included in the study. Sunshine duration and other meteorological exposures for each participant were estimated using the bilinear interpolation approach and time-weighted method. The association between sunshine duration and incident dementia was assessed using the time-dependent Cox proportional hazard model and generalized propensity score model. Multiplicative and additive interaction models were employed to identify the potential modifying effects of sociodemographic, lifestyle, environmental, and genetic factors. Brain age was predicted using machine learning methods based on neuroimaging phenotypes. The individual and joint parallel mediating effects of serum vitamin D, calcium, and brain age acceleration were further assessed using causal mediation analysis. With an average follow-up of 12.3 years, 7636 incident dementia cases were identified. Shorter sunshine duration was found to be associated with increased incidence of dementia with a hazard ratio of 1.05 (95% CI: 1.03, 1.07) for a 10-h decrease in average monthly sunshine duration. The adverse impact of reduced sunshine duration was modified by age, smoking status, household income, and time spent outdoors. The decrease in sunshine duration was also positively associated with brain age acceleration. The mediating effects of serum vitamin D, calcium, and brain age acceleration were estimated to be 16.20% (95% CI: 8.45%, 24.00%), 6.77% (95% CI: 4.01%, 9.78%), and 7.95% (95% CI: 6.48%, 9.00%), respectively, with a combined mediating proportion of 35.2%. Reduced sunshine duration associates positively with incident dementia and the brain aging process. Serum vitamin D, calcium, and brain age acceleration appear to serve as the underlying mechanism mediating the adverse impacts of reduced sunshine duration on dementia. The elderly, smokers, individuals with lower household income, and those with less time spent outdoors should be particularly vigilant.
- 31 March 2026
- Published by Scilight Press Pty Ltd in Environmental Change and Disease Dynamics
- Vol. 1 (1) , 1
Open AccessSunshine Duration and Dementia: Mediating Role of Vitamin D, Calcium, and Accelerated Brain Aging
The current evidence regarding the relationship between sunlight exposure and dementia is limited and inconclusive, with potential modifiers and underlying mechanisms remaining largely unexplored. A total of 499,627 participants from the UK Biobank were included in the study. Sunshine duration and other meteorological exposures for each participant were estimated using the bilinear interpolation approach and time-weighted method. The association between sunshine duration and incident dementia was assessed using the time-dependent Cox proportional hazard model and generalized propensity score model. Multiplicative and additive interaction models were employed to identify the potential modifying effects of sociodemographic, lifestyle, environmental, and genetic factors. Brain age was predicted using machine learning methods based on neuroimaging phenotypes. The individual and joint parallel mediating effects of serum vitamin D, calcium, and brain age acceleration were further assessed using causal mediation analysis. With an average follow-up of 12.3 years, 7636 incident dementia cases were identified. Shorter sunshine duration was found to be associated with increased incidence of dementia with a hazard ratio of 1.05 (95% CI: 1.03, 1.07) for a 10-h decrease in average monthly sunshine duration. The adverse impact of reduced sunshine duration was modified by age, smoking status, household income, and time spent outdoors. The decrease in sunshine duration was also positively associated with brain age acceleration. The mediating effects of serum vitamin D, calcium, and brain age acceleration were estimated to be 16.20% (95% CI: 8.45%, 24.00%), 6.77% (95% CI: 4.01%, 9.78%), and 7.95% (95% CI: 6.48%, 9.00%), respectively, with a combined mediating proportion of 35.2%. Reduced sunshine duration associates positively with incident dementia and the brain aging process. Serum vitamin D, calcium, and brain age acceleration appear to serve as the underlying mechanism mediating the adverse impacts of reduced sunshine duration on dementia. The elderly, smokers, individuals with lower household income, and those with less time spent outdoors should be particularly vigilant.
- Open Access
- 8 September 2021
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 6 (17)
Attenuation of cerebral edema facilitates recovery of glymphatic system function after status epilepticus
Status epilepticus (SE) is a neurological emergency usually accompanied by acute cerebral edema and long-term cognitive impairment, and is characterized by neurodegeneration and aberrant hyperphosphorylated tau protein (p-tau) aggregation. The glia-lymphatic (glymphatic) system plays a central role in facilitating the clearance of metabolic waste from the brain, but its relationship with cerebral edema and cognitive dysfunction after SE is unclear. We hypothesized that cerebral edema after SE might impair glymphatic system function through compression, thus leading to impaired removal of metabolic waste, and ultimately affecting long-term cognitive function. Our results showed that glymphatic system function was temporarily impaired, as evidenced by 2-photon imaging, MRI enhancement, imaging of brain sections, and astrocytic water channel aquaporin 4 (AQP4) protein polarization. The severity of cerebral edema on MRI correlated well with glymphatic system dysfunction within 8 days following SE. Moreover, when cerebral edema was alleviated by glibenclamide treatment or genetic deletion of Trpm4 , post-SE glymphatic system function recovered earlier, along with fewer p-tau–deposited neurons and neuronal degeneration and better cognitive function. These findings suggest that SE-induced cerebral edema may cause glymphatic system dysfunction and render the post-SE brain vulnerable to p-tau aggregation and neurocognitive impairment.
- 8 September 2021
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 6 (17)
Open AccessAttenuation of cerebral edema facilitates recovery of glymphatic system function after status epilepticus
Status epilepticus (SE) is a neurological emergency usually accompanied by acute cerebral edema and long-term cognitive impairment, and is characterized by neurodegeneration and aberrant hyperphosphorylated tau protein (p-tau) aggregation. The glia-lymphatic (glymphatic) system plays a central role in facilitating the clearance of metabolic waste from the brain, but its relationship with cerebral edema and cognitive dysfunction after SE is unclear. We hypothesized that cerebral edema after SE might impair glymphatic system function through compression, thus leading to impaired removal of metabolic waste, and ultimately affecting long-term cognitive function. Our results showed that glymphatic system function was temporarily impaired, as evidenced by 2-photon imaging, MRI enhancement, imaging of brain sections, and astrocytic water channel aquaporin 4 (AQP4) protein polarization. The severity of cerebral edema on MRI correlated well with glymphatic system dysfunction within 8 days following SE. Moreover, when cerebral edema was alleviated by glibenclamide treatment or genetic deletion of Trpm4 , post-SE glymphatic system function recovered earlier, along with fewer p-tau–deposited neurons and neuronal degeneration and better cognitive function. These findings suggest that SE-induced cerebral edema may cause glymphatic system dysfunction and render the post-SE brain vulnerable to p-tau aggregation and neurocognitive impairment.